Effects of Oxytocin on Neural Activation Patterns During Social Cognitive Tasks in Patients With Schizophrenia
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 27 May 2016
At a glance
- Drugs Oxytocin (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Acronyms MEG
- 10 May 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Dec 2016.
- 09 Feb 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.
- 09 Feb 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.